期刊文献+

cyclin E与P27蛋白在子宫腺肌病中的表达及临床意义 被引量:1

Study On Expression of Cyclin E and p27 in Adenomyosis and Their Clinicai Significance
下载PDF
导出
摘要 目的探讨周期素E(cyclinE)与P27蛋白在于宫腺肌病中的表达及意义。方法对40例子宫腺肌病(观察组)采用免疫组织化学的方法(S-P)检测cyclinE与P27蛋白的表达,并与30例正常宫内膜组织(对照组)相比较。结果cyclinE在子宫腺肌病中的表达明显高于正常宫内膜组织,P27蛋白在子宫腺肌病中的表达明显低于正常宫内膜组织,经统计学处理差异有显著性(P<0.05)。在子宫腺肌病中,cyclinE高表达及P27低表达与痛经、异位内膜浸润肌层深度及腺肌瘤的大小有关,而与月经过多无明显关系。结论cyclinE及P27蛋白与子宫腺肌病的发生、发展关系密切。 Objective To study the expression of cyclin E and p27 in adenomyosis and their clinical significance. Methods Immunohistochemical S-P method was employed to detect the experession of cyclin E and p27 in adenmyosis group (40 cases) and mormal endometrial tissue group (30 cases, control group). Results Cyclin E expression level was found to be statistically higer in adenomyosis than in noemal tissue ( P 〈 0.05 ), Significant difference in p27 exprssion was observed between the adenomyosis group and the control group. The expression level of p27 was found to be higher in the control group than in the adenmyosis group ( P 〈 0.05 ). The high expression of cyclin E and the low expression of p27 in uterine leiomyoma were closely related to dysmenorrhea, the infiltration depth of endometriosis, and the size of adenomyoma, but had no relation to menorrhagia. Conclusion As cell cycle regulatory factors, p27 and cyclin E might be invoved in the development of adenomyosis. The synergistic effect of the chants in cyolin E and p27 may promote the develoment of adenomysis and predict patients'poor prognosis.
出处 《临床军医杂志》 CAS 2007年第1期13-15,共3页 Clinical Journal of Medical Officers
关键词 子宫腺肌病 周期素E P27 细胞周期 免疫组织化学 endometriosis oylin E p27 cell cycle immunohistochemistry
  • 相关文献

参考文献4

  • 1Geng Y,Eaton E N,Picon M,et al.Regulation of cyclin E transcription by E2Fs and retinoblastoma protein[J].Oncogerne,1996,12(6):1173-1180.
  • 2Singh S P,Lipman J,Goldman H,et al.Loss or altered subcellular localization of P27 in Barrett's associated adenocarcionma[J].Cancer Ras,1998,58(8):1730-1735.
  • 3Zhang Y,Lin S C.Molecular characterization of the cyclin-dependent kinase inhibitor P27 pomoter[J].Biochim Biophys Acta,1997,1353(3):307-317.
  • 4任丽丽,齐立,宋维汉.p27^(kip1)的功能研究及其与肿瘤的关系[J].国外医学(生理病理科学与临床分册),2002,22(4):365-367. 被引量:5

二级参考文献17

  • 1Fero ML, Randel E, Gurley KE, et al. The murine gene p27Kipl is haplo-insufficient for tumour suppression[J]. Nature, 1998,396:177-180.
  • 2Ponce-CastanedaMV,LeeM-H,LatresE, etal. p27Kipl: chromosomal mapping to 12p12-12p13. 1 and absence of mutations in human tumors [J].Cancer Res, 1995, 55:1211 - 1214.
  • 3Bullrich F, Maclachlan TK, Nietal S. Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and P1TALRE, and a cdk inhibitor, p27Kipl, to regions involved in human cancer[J]. Cancer Res, 1995,55:1199.
  • 4Wang QM, Jones JB, studzinski GP, et al. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells[J]. Cancer Res,1996,56:264-267.
  • 5Liu M, Lee M, Cohen M, et al..Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937[J]. Genes Dev, 1996, 10:142-153.
  • 6Yamamoto H, Soh JW, Shirin H, et al. Comparative effects of overexpression of p27^Kipl and p21^Cipl/Wafl on growth and differentiation in human colon carcinoma cells[J]. Oncogene, 1999,18:103 - 115.
  • 7Ohtani M, lsozaki H, Fujii K, et al. Chaos and spectral analyses of heart rate variability during head-up tilting in essential hypertension[J].Cancer, 1999,85(8): 1711 - 1718.
  • 8Ophascharoensuk V, Fero ML, Hughes J, et al. The cyclin-dependant kinase inhibitor p27Kipl safeguarfs against inflammatory injury[J]. Niat Med, 1998, 4:575 - 580.
  • 9Eymin B,Haugg M,Droin N, etal. p27Kipl induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3activation in leukemic cells[J]. Oncogene, 1999, 18:1411 - 1418.
  • 10Ito Y, Matsuura N, Sakom M, et al. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group[J]. Hepatology, 1999,30(1) : 90-98.

共引文献4

同被引文献21

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部